Medicare Enrolled
Dr. Alexander Gershman, MD
Optician · Los Angeles, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gershman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gershman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gershman
Dr. Alexander Gershman is an optician specialist in Los Angeles, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gershman performed 14,079 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gershman received a total of $7,135 from 50 pharmaceutical and/or device companies across 296 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gershman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 6% volume in CA
$7,135 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗14,079
Medicare services
Top 6% in CA for optician
Not available
Unique patients (not deduplicated)
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
1,908 | $3 | $15 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
1,665 | $63 | $400 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
1,664 | $94 | $400 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,341 | $107 | $350 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
1,241 | $11 | $100 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
948 | $145 | $400 |
| Injection, garamycin, gentamicin, up to 80 mg | 941 | $2 | $5 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
564 | $16 | $60 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
493 | $106 | $450 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
334 | $35 | $150 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 324 | $136 | $600 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
260 | $127 | $350 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
241 | $716 | $2,700 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
188 | $293 | $1,050 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
174 | $46 | $200 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
163 | $105 | $453 |
| Electrical stimulation therapy Application of electrical stimulation to one or more body areas as part of a therapy plan. This procedure is used for indications other than wound care. |
163 | $11 | $60 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
144 | $688 | $2,500 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
143 | $89 | $430 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
134 | $37 | $150 |
| Biofeedback training for bowel or bladder control, initial 15 minutes A 15-minute session using biofeedback techniques to help patients gain control over bowel or bladder functions. The training involves monitoring physiological processes to learn how to manage muscle activity. |
129 | $72 | $300 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
113 | $63 | $350 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
108 | $31 | $120 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
94 | $41 | $250 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
57 | $21 | $87 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
56 | $123 | $700 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
54 | $123 | $500 |
| Simple change of bladder tube | 52 | $87 | $300 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
50 | $51 | $200 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
49 | $333 | $1,200 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
49 | $178 | $500 |
| Complicated insertion of bladder tube | 46 | $130 | $450 |
| Rectal sensitivity and function study A test to evaluate the sensitivity and functional performance of the rectum. |
45 | $249 | $900 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 35 | $236 | $900 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
26 | $213 | $900 |
| Prostate tissue destruction using radiofrequency heated water vapor A procedure that destroys prostate tissue by using radiofrequency energy to heat water vapor. This method is applied to treat the prostate gland. |
24 | $1,552 | $6,600 |
| Home visit, established patient, high complexity A home visit for an established patient involving high-level medical decision making, lasting at least 60 minutes. |
22 | $151 | $434 |
| New patient office visit, complex (60-74 min) | 13 | $188 | $450 |
| Home visit, new patient, moderate complexity A home visit for a new patient involving moderate medical decision making, lasting at least 60 minutes. |
13 | $120 | $600 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $570 | $3,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,135
Total received (2018-2024)
Avg $1,019/year across 7 years
Top 18% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
296
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,123
2023
$746
2022
$1,199
2021
$895
2020
$746
2019
$1,182
2018
$1,245
Payments by company (2024)
Sumitomo Pharma America, Inc.
$251
Dendreon Pharmaceuticals LLC
$235
Boston Scientific Corporation
$152
PFIZER INC.
$139
COLOPLAST CORP
$88
Teleflex LLC
$80
UROGEN PHARMA, INC.
$58
Astellas Pharma US Inc
$24
Novo Nordisk Inc
$23
Endo Pharmaceuticals Inc.
$22
Calyxo, Inc.
$18
PROGENICS PHARMACEUTICALS, INC.
$18
ACCORD HEALTHCARE, INC.
$15
Top 3 companies account for 56.8% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,251
PFIZER INC.
$756
Boston Scientific Corporation
$734
Amgen Inc.
$551
Sumitomo Pharma America, Inc.
$515
Dendreon Pharmaceuticals LLC
$481
Allergan Inc.
$238
Teleflex LLC
$237
Endo Pharmaceuticals Inc.
$223
BOSTON SCIENTIFIC CORPORATION
$219
UROVANT SCIENCES INC
$210
Acerus Pharmaceuticals Corporation
$134
Myriad Genetic Laboratories, Inc.
$122
COLOPLAST CORP
$120
Coloplast Corp
$100
AMAG Pharmaceuticals, Inc.
$94
Profound Medical Corp.
$90
Myovant Sciences Inc.
$84
Takeda Pharmaceuticals U.S.A., Inc.
$66
UroGen Pharma, Inc.
$60
Progenics Pharmaceuticals, Inc.
$59
UROGEN PHARMA, INC.
$58
Ethicon US, LLC
$46
MEDIVATION FIELD SOLUTIONS LLC
$41
Novo Nordisk Inc
$41
Mission Pharmacal Company
$40
BAXTER HEALTHCARE
$34
Metuchen Pharmaceuticals
$33
Ferring Pharmaceuticals Inc.
$33
Intuitive Surgical, Inc.
$32
ABBVIE INC.
$31
Janssen Biotech, Inc.
$28
Horizon Therapeutics plc
$27
Axonics, Inc.
$26
180 Medical, Inc.
$25
Hikma Pharmaceuticals USA
$24
C. R. Bard, Inc. & Subsidiaries
$24
GlaxoSmithKline, LLC.
$22
Avadel Specialty Pharmaceuticals, LLC
$22
Augmenix, Inc.
$22
Duchesnay USA Incorporated
$21
AKRIMAX PHARMACEUTICALS, LLC
$20
Merck Sharp & Dohme LLC
$19
Laborie Medical Technologies Corp.
$19
UroViu Corporation
$19
Calyxo, Inc.
$18
PROGENICS PHARMACEUTICALS, INC.
$18
COVIDIEN LP
$18
ACCORD HEALTHCARE, INC.
$15
Hollister Incorporated
$14
Top 3 companies account for 38.4% of all-time payments
Associated products mentioned in payments ›
AMS · AMS 700 · AMS 700 CXR RTE Kit · AMS Ambicor · AVYCAZ · AdVance XP · Altis · Amitiza · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CVAC ASPIRATION SYSTEM · Da Vinci Surgical System · Dexilant · EVENITY · Erleada · FLOSEAL · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL BPH · INTRAROSA · JELMYTO · KEYTRUDA · KRYSTEXXA · LIGASURE · MYRBETRIQ · Mitigare · Motegrity · Myrbetriq · NOCDURNA · NUCALA · Natesto · Noctiva · ONLI · ORGOVYX · Osphena · PREMARIN · PROVENGE · PVC · PYLARIFY · Prolaris · Prolia · Rezum Generator · SOLESTA · STRATAFIX · SURGIFLO Hemostatic Matrix Family of Products · Solyx SIS System · SpaceOAR · SpeediCath · Stendra · TITAN · TOVIAZ · Titan · Tulsa-Pro · Uribel · Uro-G Flexible Cystoscope · UroLift System · Urocit-K · VESICARE · Veozah · Wegovy · XIAFLEX · XTANDI · ZYTIGA · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
1,540
County median income
$87,760
Nearest hospital to ZIP centroid (approximate)
CEDARS-SINAI MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gershman is a clinical cardiology specialist, with above-average Medicare volume (top 6% in CA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gershman experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Gershman performed 1,908 urinalysis, manual services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gershman receive payments from pharmaceutical companies?
Yes. Dr. Gershman received a total of $7,135 from 50 companies across 296 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gershman's costs compare to other opticians in Los Angeles?
Dr. Gershman's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gershman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Los Angeles
Browse opticians in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology